Aerogen Pharma Limited

Quick facts

Phase 2 pipeline

• AeroFact · Respiratory
  AeroFact is a medication that helps to improve lung function in patients with chronic obstructive pulmonary disease (COPD) by facilitating the delivery of inhaled medications.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Aerogen Pharma Limited portfolio CI brief
• Aerogen Pharma Limited pipeline updates RSS

Related

• Sector hub: All tracked pharma companies